Kusunoki_2011_Eur.J.Pharmacol_668_486

Reference

Title : Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886 - Kusunoki_2011_Eur.J.Pharmacol_668_486
Author(s) : Kusunoki M , Tsutsumi K , Sato D , Nakamura A , Habu S , Mori Y , Morishita M , Yonemoto T , Miyata T , Nakaya Y , Nakamura T
Ref : European Journal of Pharmacology , 668 :486 , 2011
Abstract : Kusunoki_2011_Eur.J.Pharmacol_668_486
ESTHER : Kusunoki_2011_Eur.J.Pharmacol_668_486
PubMedSearch : Kusunoki_2011_Eur.J.Pharmacol_668_486
PubMedID: 21835171

Related information

Citations formats

Kusunoki M, Tsutsumi K, Sato D, Nakamura A, Habu S, Mori Y, Morishita M, Yonemoto T, Miyata T, Nakaya Y, Nakamura T (2011)
Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886
European Journal of Pharmacology 668 :486

Kusunoki M, Tsutsumi K, Sato D, Nakamura A, Habu S, Mori Y, Morishita M, Yonemoto T, Miyata T, Nakaya Y, Nakamura T (2011)
European Journal of Pharmacology 668 :486